Back
Nihon Kohden Vs. Nxera Pharma Industry Stock Comparison
Buy
53
NHNKY
Nihon Kohden
Last Price:
13.67
Seasonality Move:
6.21%
Sell
21
SOLTF
Nxera Pharma
Last Price:
6.95
Seasonality Move:
17.26%
Buy
53
Nihon Kohden (NHNKY)
is a Buy
Is Nihon Kohden a Buy, Sell or Hold?
- The current Nihon Kohden [NHNKY] share price is $13.67. The Score for NHNKY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- NHNKY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
21
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $6.95. The Score for SOLTF is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NHNKY Stock Price Chart
What is Nihon Kohden's stock price today?
-
The Nihon Kohden share price today is $13.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NHNKY is experiencing slight selling pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $6.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NHNKY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 46.26 | Sell |
Chaikin Money Flow: | -263 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.69 - 14.97) | Sell |
Bollinger Bands (100): | (13.29 - 15.25) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 18.38 | Sell |
Chaikin Money Flow: | 600 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.46 - 8.12) | Sell |
Bollinger Bands (100): | (7.68 - 9.78) | Sell |
NHNKY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.98 | Sell |
20-day SMA: | 14.18 | Sell |
50-day SMA: | 14.48 | Sell |
200-day SMA: | 14.19 | Sell |
8-day EMA: | 13.96 | Sell |
20-day EMA: | 14.15 | Sell |
50-day EMA: | 14.36 | Sell |
200-day EMA: | 14.2 | Sell |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.35 | Sell |
20-day SMA: | 7.77 | Sell |
50-day SMA: | 7.95 | Sell |
200-day SMA: | 9.31 | Sell |
8-day EMA: | 7.39 | Sell |
20-day EMA: | 7.63 | Sell |
50-day EMA: | 7.98 | Sell |
200-day EMA: | 9.17 | Sell |
Nihon Kohden Earnings Growth & NHNKY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nihon Kohden Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |